Vertex Pharmaceuticals Incorporated (0QZU.L) Stock Price
$450.1 1.9%
to add to portfolio
AI Score

-
Alternative
8 -
Fundamental
8 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Vertex Pharmaceuticals Incorporated, AI stock picks, stock alerts and much more.
0QZU.L AI Stock Analysis
AI stock analysis for 0QZU.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Vertex Pharmaceuticals Incorporated (0QZU.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Vertex Pharmaceuticals Incorporated (0QZU.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Vertex Pharmaceuticals Incorporated (0QZU.L), currently trading at $450.1, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0QZU.L

-
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis.
-
Symbol
0QZU.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
115.9B
Similar Stocks
![]() |
Waters Corporation 0LTI.L |
$403.7 0.7% |
5 |
![]() |
Neurocrine Biosciences 0K6R.L |
$116.9 0.9% |
8 |
![]() |
Emergent BioSolutions Inc. 0IGA.L |
$9.41 1.4% |
5 |
![]() |
Abeona Therapeutics Inc. 0H7R.L |
$5.72 0.3% |
4 |
![]() |
Walgreens Boots Alliance 0LSZ.L |
$9.54 1.3% |
5 |
News
0QZU.L Alternative Data
Web Traffic
Vertex Pharmaceuticals Incorporated receives an estimated 406122 monthly visitors to vrtx.com, which is up by 19.2% over the last month.
-
Web Traffic
406122
-
Change from Previous Month
19.2%
-
3 Month Change
21.9%
News Mentions
Vertex Pharmaceuticals Incorporated was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Vertex Pharmaceuticals Incorporated has 71,251 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.
-
Twitter Followers
71251
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
1%
Facebook Engagement
Vertex Pharmaceuticals Incorporated has engaged 183 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
183
-
Daily Change
10.2%
-
1 Month Change
64.3%
-
3 Month Change
94.6%
Instagram Followers
Vertex Pharmaceuticals Incorporated has 11,290 Instagram Followers on its main Instagram account, up by 0.9% over the last month.
-
Instagram Followers
11290
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
4.6%
Youtube Subscribers
Vertex Pharmaceuticals Incorporated has 2,420 subscribers on its main Youtube channel, up by 2.5% over the last month.
-
Youtube Subscribers
2420
-
Daily Change
0%
-
1 Month Change
2.5%
-
3 Month Change
6.1%
LinkedIn Followers
420,713 are following Vertex Pharmaceuticals Incorporated on LinkedIn, up by 3% over the last month.
-
LinkedIn Followers
420713
-
Daily Change
0.1%
-
1 Month Change
3%
-
3 Month Change
6.2%
Job Postings
Vertex Pharmaceuticals Incorporated currenly has an estimated 216 open job postings, up by 12.5% over the last month.
-
Job Postings
216
-
Daily Change
0%
-
1 Month Change
12.5%
-
3 Month Change
3.1%
LinkedIn Employees
According to LinkedIn, Vertex Pharmaceuticals Incorporated has 5,752 employees, up by 0.5% over the last month.
-
LinkedIn Employees
5752
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
5.4%
Business Outlook
-
Business Outlook
92
-
Change from Previous Month
1.1%
-
3 Month Change
0%
-
YoY Change
0%
0QZU.L Financials
0QZU.L Key Metrics
-
Total Revenue
$2.8B
-
Net Income
$1B
-
Earnings per Share
$4.05
-
Free cash flow
$1.5B
-
EBITDA
$1.1B
-
EBITDA Ratio
0.40272
-
Total Assets
$22.2B
0QZU.L 2-year Revenue & Income
0QZU.L 2-year Free Cash Flow
0QZU.L Technicals
0QZU.L SMA
0QZU.L RSI
FAQ
What's the current price of Vertex Pharmaceuticals Incorporated (0QZU.L) Stock?
The price of an Vertex Pharmaceuticals Incorporated (0QZU.L) share is $450.1.
What's the market cap of Vertex Pharmaceuticals Incorporated?
The current market cap of Vertex Pharmaceuticals Incorporated is 115.9B.
Should I buy or sell 0QZU.L?
Multiple alternative data signals suggest that Vertex Pharmaceuticals Incorporated stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Vertex Pharmaceuticals Incorporated a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Vertex Pharmaceuticals Incorporated stock. The bullish indicators suggest that Vertex Pharmaceuticals Incorporated's growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Vertex Pharmaceuticals Incorporated (0QZU.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Vertex Pharmaceuticals Incorporated stock, given the bullish outlook.
What are some stocks similar to Vertex Pharmaceuticals Incorporated (0QZU.L) that investors often compare it to?
Vertex Pharmaceuticals Incorporated (0QZU.L) is often compared to similar stocks such as Waters Corporation, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.
What is the forecast for Vertex Pharmaceuticals Incorporated's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Vertex Pharmaceuticals Incorporated's stock price to be around $510 in 2026. Starting from the current price of $450.1, this represents a 13.3% change in price, indicating a bullish outlook for the stock.
How to buy Vertex Pharmaceuticals Incorporated (0QZU.L) Stock?
Vertex Pharmaceuticals Incorporated stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Vertex Pharmaceuticals Incorporated shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.